Yingli Ma's most recent trade in Structure Therapeutics Inc - ADR was a trade of 40,278 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc (ADR) | Yingli Ma | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 40,278 | 40,278 | - | - | Employee Stock Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Yingli Ma | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 32,526 | 139,917 | - | 0 | Ordinary Shares | |
| Structure Therapeutics Inc (ADR) | Yingli Ma | CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.84 per share. | 01 Jul 2025 | 4,470 | 118,704 | - | 6.8 | 30,560 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Yingli Ma | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 155,040 | 155,040 | - | - | Employee Stock Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Yingli Ma | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 63,810 | 100,539 | - | 0 | Ordinary Shares | |
| Structure Therapeutics Inc (ADR) | Yingli Ma | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 24,459 | 123,174 | - | 0 | Ordinary Shares | |
| Structure Therapeutics Inc (ADR) | Yingli Ma | CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.92 per share. | 01 Mar 2025 | 1,824 | 98,715 | - | 7.9 | 14,440 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Yingli Ma | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 91,494 | 91,494 | - | - | Stock Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Yingli Ma | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 91,494 | 91,494 | - | - | Stock Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Yingli Ma | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 36,729 | 36,729 | - | 0 | Ordinary Shares |